MedCap AB (publ) (FRA:61MA)

Market Cap	766.70M
Revenue (ttm)	180.16M
Net Income (ttm)	17.81M
Shares Out	n/a
EPS (ttm)	1.19
PE Ratio	43.05
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	50.30
Previous Close	50.50
Day's Range	50.30 - 50.30
52-Week Range	29.40 - 59.60
Beta	n/a
RSI	55.77
Earnings Date	Feb 6, 2026

About MedCap AB

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, pharmaceuticals, med tech and assistive tech companies. The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Nordic region and Northern Europe. It typically invests between SEK25 millio...

• Industry: Investors, not elsewhere classified
• Founded: 2001
• Employees: 592
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 61MA

Financial Performance

In 2024, MedCap AB's revenue was 1.81 billion, an increase of 13.74% compared to the previous year's 1.59 billion. Earnings were 207.40 million, an increase of 20.44%.

Financial numbers in SEK